Global Financial Private Capital’s Biogen BIIB Stock Holding History

Global Financial Private Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.13M	Buy	+4,224	New	+$1.27M	0.07%	194

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Global Financial Private Capital's BIIB Position: Q2 2020 in Review

Global Financial Private Capital opened a new position in Biogen (BIIB) in Q2 2020: 4,224 shares worth $1.13M. The stake represents 0.07% of the portfolio and ranks #194 among its holdings.

1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Global Financial Private Capital held 4,224 shares of Biogen worth $1.13M as of Q2 2020.
Biogen was a new Global Financial Private Capital position in Q2 2020.
Biogen made up 0.07% of Global Financial Private Capital's portfolio in Q2 2020, its #194 holding.
1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.